This is the authors' abstract. We don't add key points for this paper.
Dear Editor,We read with great interest the original article from Diego García-Compeán et al. [1], recently published in this journal. To the best of our knowledge, this is the first article providing an objective method that could fill the gap in the evaluation of the severity of small bowel angiodysplasia (SBAD) based on small bowel capsule endoscopy findings. It was shown that Capsule Endoscopy Small Bowel Angiodysplasia Activity Index (CESBAI) is a simple and reproducible method, with low interobserver variability regarding SBAD evaluation by small bowel capsule endoscopy. This is a very relevant topic in clinical practice and might be an important complement, after its validation, to other existing scores for assessing the risk of small bowel rebleeding, such as the RHEMITT score created by our group, which was further externally validated. This score includes seven variables, namely, renal disease, heart failure, endoscopic capsule P1/P2 lesions, major bleeding, incomplete capsule, tobacco consumption, and endoscopic treatment. It was shown that it has an excellent accuracy in predicting rebleeding and can stratify patients into three groups according to rebleeding risk: low (0–3 points); intermediate (4–10 points); and high (+11 points) 2‒5.We would, however, like to point out a possible source of misinterpretation regarding the calculation of CESBAI score. In the article’s Methods section, it is described that CESBAI consists of the evaluation of 3 variables: extension (E) of the SBAD, number (N) of SBAD, and probability (P) of bleeding association. As it is shown in article’s Table 1, these variables were classified into different degrees of severity (E1: lesions are located in the upper or lower half of the length of the small intestine, E2: lesions are located in both halves of the small intestine; N1: <5, N2: 5–10, N3: >10; P1: pale red spots, P2: bright red spots, P3: nonactively bleeding lesion with stigmata of recent bleeding, P4: flat patchy lesion with active bleeding) and the total CESBAI was calculated using the following formula: E × 1 + N × 2 + P × 3. It is also referred, in the Discussion section, that the 3 endoscopic variables were graded on a scale from 1 to 4. Taking this into account, we could not find any possible explanation for the fact that is mentioned in the Results section and illustrated in Table 2 that CESBAI could have a value of 0 (“The CESBAI values of each individual are shown in Table 2. They range from 0 to 20 points”). If each variable subscore is graded on a scale from 1 to 4 using the previous formula, it could not exist with a total CESBAI of 0.Finally, we must also mention that, although according to the methodology of this study “red spots” were considered as a synonym of “angioectasia” independently of their size and characteristics, this could lead to the inclusion of punctiform red spots when applying this score and lead to erroneous results, as red spots are different lesions than typical angioectasias, with different risk of bleeding, corresponding to P1 lesions in the Saurin classification, i.e., likely nonsignificant with very low risk of bleeding [6].We feel that these incoherencies may lead to erroneous calculation and interpretation of CESBAI and is putting at risk its reproducibility, precluding its further validation and applicability in clinical practice. In this regard, we would like the authors to possibly clarify their methods and findings, namely, with a more detailed explanation regarding the calculation of the final and each CESBAI subscore, so that other authors can properly calculate and report CESBAI in order to further test the clinical applicability of this scoring system, for example, its capability of predicting rebleeding and endoscopic treatment in these patients.The authors have no conflicts of interest to declare.Authors declare that no funding was received in the preparation of data or the manuscript.Tiago Lima Capela was involved in the conception and design of the work, drafting the work, and final approval of the version to be published. Tiago Cúrdia Gonçalves, Bruno Rosa, and José Cotter were involved in revising the work critically for important intellectual content and final approval of the version to be published.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Capela et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: